To assess the effect of two selective serotonin reuptake inhibitors ( SSRIs ) , fluvoxamine and citalopram , that markedly differ in their level of cytochrome P450 ( CYP ) 2C19 inhibition , on the laboratory response to clopidogrel , a prodrug requiring metabolism by the CYP system , and especially CYP2C19 , to produce its active form .